// App-Quantinova.ai

: Protein truncating mutations in ATP13A3 promote pulmonary arterial hypertension

Researchers

Presenter

  • Ekaterina Legchenko

Principal Investigators

  • Bin Liu

  • James West

  • Peter Vangheluwe

  • Paul Upton

  • Nicholas Morrell

Medical Centers

  • Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  • Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Locations

  • United Kingdom

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved